The University of Southampton
University of Southampton Institutional Repository

The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review

The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review
The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review
The success of prevention of mother to child transmission programmes over the last two decades has led to an increasing number of infants who are exposed to human immunodeficiency virus (HIV), but who are not themselves infected (HIV-exposed, uninfected infants). Although the morbidity and mortality amongst HIV-exposed, uninfected infants is considerably lower than that amongst HIV-infected infants, they may remain at increased risk of infections in the first two years of life compared to their HIV-unexposed peers, especially in the absence of breastfeeding. There is some evidence of immunological differences in HIV-exposed, uninfected infants, which could play a role in susceptibility to infection. Cytomegalovirus (CMV) may contribute to the increased immune activation observed in HIV-exposed, uninfected infants. Infants born to HIV-infected women are at increased risk of congenital CMV infection, as well as early acquisition of postnatal CMV infection. In infants with HIV infection, CMV co-infection in early life is associated with higher morbidity and mortality. This review considers how HIV infection, HIV-exposure and CMV infection affect infant responses to vaccination, and explores possible immunological and other explanations for these findings. HIV-infected infants have lower vaccine-induced antibody concentrations following tetanus, diphtheria, pertussis, hepatitis B and pneumococcal vaccination, although the clinical relevance of this difference is not known. Despite lower concentrations of maternally-derived specific antibody at birth, HIV-exposed, uninfected infants respond to vaccination at least as well as their HIV-unexposed uninfected peers. CMV infection leads to an increase in activation and differentiation of the whole T-cell population, but there is limited data on the effects of CMV infection on infant vaccine responses. In light of growing evidence of poor clinical outcomes associated with CMV infection in HIV-exposed, uninfected infants, further studies are particularly important in this group. A clearer understanding of the mechanisms by which maternal viral infections influence the developing infant immune system is critical to the success of maternal and infant vaccination strategies.
1664-3224
1-11
Falconer, Olivia
adc1773a-2ab9-499f-88ca-d8422bc6d96d
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Newell, Marie-Louise
c6ff99dd-c23b-4fef-a846-a221fe2522b3
Falconer, Olivia
adc1773a-2ab9-499f-88ca-d8422bc6d96d
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Newell, Marie-Louise
c6ff99dd-c23b-4fef-a846-a221fe2522b3

Falconer, Olivia, Jones, Christine E. and Newell, Marie-Louise (2018) The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review. Frontiers in Immunology, 1-11. (doi:10.3389/fimmu.2018.00328).

Record type: Article

Abstract

The success of prevention of mother to child transmission programmes over the last two decades has led to an increasing number of infants who are exposed to human immunodeficiency virus (HIV), but who are not themselves infected (HIV-exposed, uninfected infants). Although the morbidity and mortality amongst HIV-exposed, uninfected infants is considerably lower than that amongst HIV-infected infants, they may remain at increased risk of infections in the first two years of life compared to their HIV-unexposed peers, especially in the absence of breastfeeding. There is some evidence of immunological differences in HIV-exposed, uninfected infants, which could play a role in susceptibility to infection. Cytomegalovirus (CMV) may contribute to the increased immune activation observed in HIV-exposed, uninfected infants. Infants born to HIV-infected women are at increased risk of congenital CMV infection, as well as early acquisition of postnatal CMV infection. In infants with HIV infection, CMV co-infection in early life is associated with higher morbidity and mortality. This review considers how HIV infection, HIV-exposure and CMV infection affect infant responses to vaccination, and explores possible immunological and other explanations for these findings. HIV-infected infants have lower vaccine-induced antibody concentrations following tetanus, diphtheria, pertussis, hepatitis B and pneumococcal vaccination, although the clinical relevance of this difference is not known. Despite lower concentrations of maternally-derived specific antibody at birth, HIV-exposed, uninfected infants respond to vaccination at least as well as their HIV-unexposed uninfected peers. CMV infection leads to an increase in activation and differentiation of the whole T-cell population, but there is limited data on the effects of CMV infection on infant vaccine responses. In light of growing evidence of poor clinical outcomes associated with CMV infection in HIV-exposed, uninfected infants, further studies are particularly important in this group. A clearer understanding of the mechanisms by which maternal viral infections influence the developing infant immune system is critical to the success of maternal and infant vaccination strategies.

Text
Olivia Frontiers review V4 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (799kB)
Text
fimmu-09-00328 - Version of Record
Available under License Creative Commons Attribution.
Download (173kB)
Text
Olivia Frontiers Table 1 v2
Restricted to Repository staff only
Request a copy
Text
Olivia Frontiers Table 2 v2
Restricted to Repository staff only
Request a copy
Text
Olivia Frontiers Table 3 v2
Restricted to Repository staff only
Request a copy
Text
Olivia Frontiers supplementary table 1 search terms (002)
Restricted to Repository staff only
Request a copy

Show all 6 downloads.

More information

Accepted/In Press date: 6 February 2018
e-pub ahead of print date: 2 March 2018
Published date: 2 March 2018

Identifiers

Local EPrints ID: 417811
URI: http://eprints.soton.ac.uk/id/eprint/417811
ISSN: 1664-3224
PURE UUID: 64d030b5-6c6a-4b4a-a9cb-d87fb4c2604a
ORCID for Christine E. Jones: ORCID iD orcid.org/0000-0003-1523-2368
ORCID for Marie-Louise Newell: ORCID iD orcid.org/0000-0002-1074-7699

Catalogue record

Date deposited: 14 Feb 2018 17:30
Last modified: 16 Mar 2024 06:11

Export record

Altmetrics

Contributors

Author: Olivia Falconer

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×